by Neoteryx | 2 min read
Great science and smarter research need better blood collection and stronger support. That’s the ideas behind the VAMS® Incubator Program, a powerful new resource for blood collection innovators in the …
Read Storyby Neoteryx | 2 min read
In pediatric medicine, for screening and other purposes, it is important to know the appropriate amount of blood that can be drawn from a child depending on their age. The …
Read Storyby Neoteryx | 2 min read
Capillary finger-prick blood draws have gained popularity. This is partly in response to innovations in point of care testing and remote sampling. Capillary blood has distinct advantages in hospital labs, clinical labs, …
Read Storyby Neoteryx | 2 min read
Working with traditional wet blood specimens has always raised safety concerns and posed logistical challenges. Blood sample storage and cold chain shipping require navigating an increasingly complicated maze of regulatory …
Read Storyby Neoteryx | 2 min read
For decades, Dried Blood Spot (DBS) cards have served as a useful alternative to painful venipuncutre, cold chain shipping and storage, and other hassles of wet blood collection. However, they …
Read Storyby Neoteryx | 2 min read
Capillary blood sampling is becoming a common way to minimize the amount of blood drawn from a patient. The 10 or 20 microliters can be used to look for anemia, …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.